Background And Aims: Pancreatic ductal adenocarcinoma (PDAC) is one of refractory malignancies without efficient therapeutics. Babao Dan (BBD) was partially effective to suppress tumor growth of PDAC in clinical practice. However, the molecular mechanisms were unclear.
Methods: We established PDAC mice models and treated them with BBD through intragastric administration. Treatment and control groups were then subjected to high-throughput RNA sequencing. We presented the transcriptional changes upon BBD treatment by using computational analysis comparing BBD treatment and control groups. Functional enrichment analysis was employed to investigate the biological processes or pathways that BBD modulates.
Results: BBD treatment showed strong suppression on tumor growth of PDAC, even stronger than Gemcitabine. Through differential analysis comparing BBD treatment and control groups, we identified 638 up-regulated and 259 down-regulated genes in the BBD treatment group. BBD was found to activate tumor suppressor genes, such as MTUS1, PDGFB, SOD3, and UCHL1. Furthermore, we revealed that BBD treatment inhibited cancer-related pathways and elevated activities of metabolism-related processes. The BBD-modulated metabolic genes were further showed to be associated with patient survival in an independent cohort with pancreatic cancer.
Conclusion: BBD repressed the tumor growth of PDAC. BBD treatment modulated expression of cancer-related genes in PDAC. BBD suppressed cancer-related pathways and activated metabolic processes in PDAC. Our study suggests BBD treatment as potential effective therapeutics for patients with pancreatic cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710661 | PMC |
| http://dx.doi.org/10.3389/fonc.2020.584330 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Enhanced Anti-inflammatory Effect of Puerarin through Optimized Release and Bioavailability via PDLG-Loaded Nanoparticles.
Biol Pharm Bull
January 2025
Department of Natural products, National Institute of Pharmaceutical Education and Research (NIPER).
Puerarin (PU), a bioactive constituent reported to possess therapeutic effectiveness, but it suffers a drawback of poor bioavailability. In the present study, the PU nanoparticles (PU-NPs) were prepared using solvent-diffusion-evaporation method and optimized using Box-Behnken design (BBD), a response surface methodology for obtaining the optimal material ratio of PU-NPs. Further, PU and PU-NPs were evaluated to assess their cytotoxic effect and in vitro efficiency of inflammatory responses using lipopolysaccharide-sensitive macrophage cell line (RAW264.
View Article and Find Full Text PDFThe utility of a sensitive genitourinary exam in the management of pediatric bowel and bladder dysfunction.
J Pediatr Urol
December 2024
Children's Mercy Hospital- Kansas City, 2401 Gillham Road, Kansas City, MO, 64108, USA. Electronic address:
Introduction: Bladder and bowel dysfunction (BBD) is a commonly experienced disorder that can cause adverse physical and psychological impacts on a child and their family.
Objective: This study aimed to assess the yield of clinically significant sensitive genitourinary (GU) examination findings and whether findings influence BBD management.
Methods: A cross-sectional, descriptive, correlational research design was used to study the relationship between GU examination findings and management of pediatric BBD.
Tuberculosis in adult migrants in Europe: a TBnet consensus statement.
Eur Respir J
December 2024
Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.
Introduction: Global migration has increased in recent decades due to war, conflict, persecutions, and natural disasters, but also secondary to increased opportunities related to work or study. Migrants' risk of tuberculosis (TB) differs by reasons for migration, socioeconomic status, mode of travel and TB risk in transit, TB incidence and healthcare provision in country of origin. Despite advances in TB care for migrants and new treatment strategies, decisions for the management of migrants at risk of TB often rely on expert opinions, rather than clinical evidence.
View Article and Find Full Text PDFTransitional Outcomes of Adults Who Underwent Cohen Ureteroneocystostomy for the Treatment of Vesicoureteral Reflux as Children.
Urology
December 2024
İstanbul University, İstanbul Faculty of Medicine, Turkey.
Article Synopsis
- The study aimed to assess the outcomes of children who underwent Cohen ureteroneocystostomy (UNC) for vesicoureteral reflux (VUR) over a long-term follow-up period.
- A retrospective review of 241 patients revealed that 28.6% experienced lower urinary tract dysfunction (LUTD) in adulthood, with various factors such as being female and having a history of bladder-bowel dysfunction influencing this outcome.
- Despite effective management of VUR, a small percentage of patients still faced complications like febrile urinary tract infections (UTIs) and hypertension, highlighting the need for ongoing monitoring and care even after surgical intervention.
Pharmacological investigation of against scopolamine induce amnesia and cognitive impairment in laboratory animals.
Toxicol Rep
December 2024
Department of Pharmacology, Rajiv Academy for Pharmacy, Mathura, India.
Article Synopsis
- - The study examined the effects of a specific fruit, Chiku, on memory and cognitive function in mice that experienced scopolamine-induced amnesia.
- - Swiss albino mice were divided into five groups to compare the effects of Chiku's ethanolic extract and a standard drug, Donepezil, alongside scopolamine with tests like the Morris water maze and elevated plus maze used to evaluate memory.
- - Results indicated that Chiku extract significantly improved cognitive performance and reduced oxidative stress in the brain, suggesting its potential for treating memory disorders.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!